R. Andrew Ramelmeier

2020

In 2020, R. Andrew Ramelmeier earned a total compensation of $1.5M as Executive Vice President, Technical Operations at Sangamo Biosciences, a 39% increase compared to previous year.

Compensation breakdown

Bonus$50,000
Non-Equity Incentive Plan$203,840
Option Awards$485,221
Salary$416,000
Stock Awards$374,000
Other$5,639
Total$1,534,700

Ramelmeier received $485.2K in option awards, accounting for 32% of the total pay in 2020.

Ramelmeier also received $50K in bonus, $203.8K in non-equity incentive plan, $416K in salary, $374K in stock awards and $5.6K in other compensation.

Rankings

In 2020, R. Andrew Ramelmeier's compensation ranked 6,734th out of 13,090 executives tracked by ExecPay. In other words, Ramelmeier earned more than 48.6% of executives.

ClassificationRankingPercentile
All
6,734
out of 13,090
49th
Division
Manufacturing
2,805
out of 5,620
50th
Major group
Chemicals And Allied Products
1,133
out of 2,253
50th
Industry group
Drugs
977
out of 1,953
50th
Industry
Biological Products, Except Diagnostic Substances
233
out of 411
43rd

Pay ratio

R. Andrew Ramelmeier's Pay$1,534,700
Median Employee's Pay$174,051
Pay Ratio

9

to 1

In 2020, the annual total compensation of R. Andrew Ramelmeier was $1,534,700.

The annual total compensation of the median employee at Sangamo Biosciences was $174,051.

The ratio of R. Andrew Ramelmeier's pay to the pay of median employee was therefore 9 to one.

Source: SEC filing on April 2, 2021.

Ramelmeier's colleagues

We found five more compensation records of executives who worked with R. Andrew Ramelmeier at Sangamo Biosciences in 2020.

2020

Alexander Macrae

Sangamo Biosciences

Chief Executive Officer

2020

D McClung

Sangamo Biosciences

Executive Vice President, Chief Business Officer

2020

Sung Lee

Sangamo Biosciences

Chief Financial Officer

2020

Stéphane Boissel

Sangamo Biosciences

Former Executive Vice President, Corporate Strategy

2020

Gary Loeb

Sangamo Biosciences

General Counsel

News

You may also like